Protagenic Therapeutics, Inc. (PTIX) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 New York City, NY, 美国. 现任CEO为 Garo H. Armen.
PTIX 拥有 IPO日期为 2021-04-27, 1 名全职员工, 在 NASDAQ Capital Marke, 市值为 $1.08M.
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.
